Hepatitis B

February 9, 2017February 9, 2017

NIH Awards $416,000 to Saint Louis Researchers to Advance Potential Cure for Hepatitis B

Hepatitis B, News

Researchers at Missouri’s Saint Louis University (SLU) — hoping to advance understanding on how hepatitis B virus (HBV) replicates — aim to develop a new drug that could cure this viral infection. John Tavis, PhD, professor of ... Read more

January 24, 2017January 24, 2017

GeoVax and Georgia State Working on Hepatitis B Therapeutic Vaccine

Hepatitis B, News

GeoVax Labs and the Georgia State University Research Foundation have entered a research agreement to develop a therapeutic vaccine for chronic hepatitis B virus (HBV) infections. Georgia State will combine its preS VLP ... Read more

January 19, 2017January 19, 2017

Quest Launches First US HBV Test to Assess Patients’ Response to Therapy

Hepatitis B, News

Quest Diagnostics launched a new quantitative test that will help doctors in the U.S. measure a patient’s response to therapy while being treated for hepatitis B virus (HBV) infection. Today, 2.2 ... Read more

January 17, 2017January 17, 2017

Vemlidy, for Chronic Hepatitis B Infection, Approved in Europe

Hepatitis B, News

The European Union has granted marketing authorization for Vemlidy (tenofovir alafenamide, or TAF), Gilead Sciences’ pioneering treatment for chronic hepatitis B virus (HBV) infection in adults and teens with compensated liver ... Read more

January 5, 2017January 5, 2017

ContraVir Awarded $224K Research Grant to Advance Potential Hepatitis B Treatment

Hepatitis B, News

The National Research Council (NRC) in Canada has awarded ContraVir Pharmaceuticals more than $224,000 to cover expenses related to the preclinical development of CRV431, the company’s cyclophilin inhibitor for the treatment of hepatitis B virus (HBV). The research award, ... Read more

January 3, 2017January 3, 2017

Gilead Sciences Awards Grant to Promote Best Practices for HCV, HBV and HIV Screening

Hepatitis B, Hepatitis C, News

Erie County Medical Center (ECMC) has been awarded $351,289 by Gilead Sciences to develop a model program that embodies best practices in the screening of Human Immunodeficiency Virus (HIV) and Hepatitis ... Read more

December 22, 2016December 22, 2016

Combo of RNA Interference Therapies and Antiviral Agents Treat Hepatitis B in Early Study

Hepatitis B, News

Treatments combining Benitec Biopharma’s investigative agents — BB-101, BB-102 or BB-103 — with current standard of care may be a way of treating hepatitis B virus (HBV) infection, according to results obtained ... Read more

December 15, 2016December 16, 2016

Health Professionals in Ethiopia Show Solid Knowledge of Hepatitis B in Hospital Survey

Hepatitis B, News

The majority of healthcare professionals working at University of Gondar Hospital in Ethiopia are knowledgeable of hepatitis B transmission and its risks, and the importance of a vaccination program — all important points for people ... Read more

December 6, 2016December 6, 2016

European Medical Officials Join Chorus of Warnings About Risk of Hep B Reactivation with Direct-Acting Antiviral Drugs Used for Hep C

Hepatitis B, Hepatitis C, News

The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency (EMA) has confirmed that patients being treated with certain direct-acting antiviral (DAA) drugs for hepatitis C virus (HCV) infection ... Read more

December 1, 2016December 1, 2016

HBV Infection Results When Viral Immunosuppression Beats Innate Immune Response

Hepatitis B, News

A study in tree shrews — a small mammal that also gets infected with the hepatitis B virus (HBV) — gave researchers a deeper understanding of the innate immune response processes ... Read more